期刊文献+

活性维生素D_3对糖尿病大鼠肾脏TGF-β_1和HGF表达的影响 被引量:5

Effect of 1,25-dihydroxyvitamin D_3 on renal expression of TGF-1 and HGF in type 1 diabetic rats
下载PDF
导出
摘要 目的:探讨活性维生素D3对糖尿病大鼠肾脏(Transforming growth factor-beta1,TGF-β1)和肝细胞生长因子(Hepatocyte growth factor,HGF)表达的影响。方法:雄性SD大鼠30只,按随机数字表法分为正常对照组(NC),糖尿病模型组(DM),活性维生素D3治疗组(DC),每组10只。12周后,观测肾组织形态学和肾功能变化,尿白蛋白排泄率等指标的变化,用免疫组化法检测肾脏TGF-β1表达水平的变化,RT-PCR法检测肾皮质TGF-β1mRNA、HGFmRNA表达水平的变化。结果:与NC组比较,第12周末DM组大鼠肾脏肥大指数(KW/BW)、平均肾小球体积(MGV)、系膜面积比(FMA)、尿白蛋白排泄率(UAER)、血肌酐(Scr)均明显升高(P<0.05),肾组织TGF-1mRNA及蛋白表达水平也显著升高(P<0.05),同时肾皮质HGFmRNA表达也有所增加(P<0.05)。DC组HGFmRNA的表达水平较DM组显著升高(P<0.05),而上述其他指标与DM组比较,则有明显的降低(P<0.05)。结论:活性维生素D3对于糖尿病肾脏病变至少具有部分保护作用,其机制可能为通过抑制糖尿病大鼠肾脏TGF-β1的过度表达,而上调HGF的表达,从而对糖尿病大鼠肾脏起保护作用。 Objective:To explore the effects of 1,25-dihydroxyvitamin D3 on renal expression of TGF-β1 and HGF in type 1 diabetic rats. Methods:30 Sprague-Dawley rats were randomized into 3 groups:normal control rats(group NC),diabetic rats(group DM ) and diabetic rats treated with 1,25-dihydroxyvitamin D3(group DC), Kidney-to-body weight ratio(KW/BW),mean glomerular volume (MGV), fractional mesangial area ( FMA ), urinary albumin excretion rate ( UAER )and serum creatinine (Scr)were measured after 12 weeks of treatment,while transforming growth factor-betal(TGF-β1) expression in kidney cortex were observed by imm unohistoehemistry. The expression levels of TGF-β1 mRNA and HGF mRNA were detected by reverse transcription and polymerase chain reaction(RT-PCR) at the end of the experiment. Results:UAER,Scr,MGV,FMA and KW/BW ratio were significantly higher in the diabetic rats than those in the normal control rats (P〈0.05), The expression levels of TGF- β 1 and HGF in the diabetic rats were also higher as compared with those in the normal control group (P〈0.05). UAER,Scr,MGV,FMA and KW/BW ratio and the expression levels of TGF-β1 in the 1,25-dihydroxyvitamin D3-treated group were obviously lower than those in the diabetic rats(P〈0.05),while the levels of HGFmRNA in the 1,25-dihydroxyvitamin D3-treated group were obviously higher than in diabetic rats, Conclusion: 1,25-dihydroxyvitamin D3 has some renal protective effect on diabetes in rats,partly by down-regulating TGF-β1 and up-regulating HGF expressions in renal cortex
出处 《重庆医科大学学报》 CAS CSCD 2008年第9期1058-1062,共5页 Journal of Chongqing Medical University
关键词 糖尿病肾病 活性维生素D 转化生长因子Β1 肝细胞生长因子 Streptozotocin diabetes 1,25-dihydroxyvitamin D3 TGF- β1 HGF
  • 相关文献

参考文献11

  • 1Ota T,Takamura T,Ando H,et al. Preventive effect of cefivastatin on diabetic nephropathy through suppression of glomerular maer ophage recruitment in a rat mode[J]. Diabetologia, 2003 ;46(6) : 843- 851.
  • 2Sharma K,Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator [J]. Diabetes, 1995;44(10) : 1139-1146.
  • 3刘冬舟,贾汝汉,丁国华,黄从新.肝细胞生长因子在糖尿病大鼠肾小管间质的表达及意义[J].中华肾脏病杂志,2003,19(2):125-127. 被引量:19
  • 4刘青娟,何宁,刘淑霞,王丽晖,史永红,段惠军.糖尿病肾病大鼠肾小管上皮细胞转化与肝细胞生长因子的表达[J].中国慢性病预防与控制,2005,13(6):266-268. 被引量:6
  • 5Liu Y,Rajur K,Tolbert E,et al. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways[J]. Kidney Int, 2000; 58 (5) : 2028-2043.
  • 6Mizuno S,Nakamura T. Suppressions of chronic glomemlar injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy[J]. Am J Physiol Renal Physiol,2004;286(1): F134-143.
  • 7Makibayashi K,Tatematsu M,Hirata M,et al. A vitamin Danalog ameliorates glomerular injury on rat glomerulonephfitis[J]. Am J Pathol, 2001 ; 158(5 ): 1733-1741.
  • 8Panichi V,Migliori M,Taccola D,et al. Effects of 1,25-Dihydroxyvitamin D3 in experimental mesangial proliferative nephritis in rats[J]. Kidney Int,2001 ;60( 1 ) :87-95.
  • 9Li Y,Spataro BC,Yang J,et al.1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibrobiast activation by inducing hepatocyte growth factor expression[J]. Kidney Int, 2005 ; 68(4) : 1500-1510.
  • 10Del Pino-Montes J,Femandez Salazar MP,Benito GE,et al. Effect of 1.25-(OH)2 Vitamin D3 on bone mineral density of diabeti c rat[J]. Bone, 1998 ; 23 (s5) : S643.

二级参考文献10

  • 1Meyer TW. Tubular injury in glomerular disease [J]. Kidney Int,2003,63: 774-787.
  • 2Okon K. Tubulo-interstitial changes in glomerulopathy.Ⅱ. Prognostic significance[J]. Pol J Pathol,2003, 54: 163-169.
  • 3Muchaneta-Kubara EC, el Nahas AM. VEGF and diabetic microvaseular complieations[J]. Nephrol Dial Transplant,1997, 12: 1538.
  • 4Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats[J]. Kidney Int, 1992, 41: 891-897.
  • 5Brownlee M. Bilchemistry and molecular cell biology of diabetic complication of diabetes mellitus[J]. Annu Rev Biochem Nature,2001,414:813 -820.
  • 6Strutz F, Caron R, Tomaszewski J. Transdifferentiation: a new concept in renal fibrogenesis[J]. J Am Soc N ephrol,1994, 5: 819.
  • 7Ng YY, Huang TP, Yang WC, et al. Tubular epithelial- myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats[J]. Kidney Int,1998, 54: 864-876.
  • 8Taniguchi Y, Yorioka N, Y amashita K,et al. Localization of hepatocyte growth factor and tubulointerstitial lesion in IgA nephropathy[J]. Am J Nephrol,1997, 17: 413-416.
  • 9Liu Y, Tolbert WM, Sun AM, et al.In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rats[J]. Am J Physiol,1996, 271:1202-1210.
  • 10Yang JW, Liu YH. Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor prevents Renal Interstitial Fibrosis[J]. J Am Soc Nephrol,2002, 13: 96-107.

共引文献23

同被引文献78

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部